Mixi-Bio
(2 customer reviews)

MoxiBio

Moxifloxacin is a fourth generation synthetic fluoroquinolone. It has in vitro activity against a wide range of gram-positive, gram-negative, atypical and anaerobic pathogens. The bactericidal action of MOFOXIN  results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair. Pharmacodynamic investigations have demonstrated thatMOFOXIN  exhibits a concentration dependent killing rate.


Composition

Each film coated tablet contains:

Moxifloxacin Hydrochloride equivalent to Moxifloxacin 400 mg

Indications & Dosage

Infection

Daily Dose

Duration

Acute Bacterial Sinusitis 400 mg 10 days
Acute Bacterial Exacerbation of Chronic Bronchitis 400 mg 5 days
Community Acquired Pneumonia 400 mg 7-14 days
Uncomplicated Skin and Skin Structure Infections 400 mg 7 days
Complicated Skin and Skin Structure Infections 400 mg 7-21 days
Complicated Intra-Abdominal Infections 400 mg 5-14 days

Product reviews

There are no reviews yet.

Be the first to review “MoxiBio”

Privacy Preference Center